Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with U.S. FDA PDUFA goal date of August 15, 2025 ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

Almost everyone has been infected by age 2. However, according to the Centers for Disease Control and Prevention, an ...

VMPL New Delhi [India] January 31 Allergic rhinitis is a very common condition often termed as hay fever which affects millions of people globally This chronic condition arises from the reaction of th ...

It was an everyday situation that became a nightmare no parent should have to face. Two-year-old Ava Hodgkinson was under the ...

Should children at Philadelphia extended-day school programs administer their own medication in a health emergency? A former school board member said that’s what she was told her child should do.